Gut microbiota in older subjects: Variation, health consequences and dietary intervention prospects

Proceedings of the Nutrition Society

Volumn 73, Issue 4, 2014, Pages 441-451

  O'Connor, Eibhlís M ^a   O'Herlihy, Eileen A ^b   O'Toole, Paul W ^b,c  

^a UNIVERSITY OF LIMERICK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Ageing; Diet; Health; Microbiota

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

ACTINOBACTERIA; ADIPOGENESIS; BACTEROIDETES; BIFIDOBACTERIUM; CONFERENCE PAPER; DIET; DIET SUPPLEMENTATION; ENERGY; FIRMICUTES; HUMAN; INFLAMMATION; INTESTINE FLORA; LIPID METABOLISM; LIPID STORAGE; MICROBIOME; MICROFLORA; NUTRITION; OBESITY; PREVOTELLA; PROTEOBACTERIA; AGED; DIABETES MELLITUS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; MICROBIOLOGY; PHYSIOLOGY;

BACTERIA (MICROORGANISMS);

ADIPOGENESIS; AGED; DIABETES MELLITUS; DIET; DIETARY SUPPLEMENTS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; LIPID METABOLISM; MICROBIOTA; OBESITY; PREBIOTICS;

EID: 84927911004     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665114000597     Document Type: Conference Paper

References (122)

1. Ley RE, Peterson DA & Gordon JI (2006) Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124, 837-848.
2. Fraher MH, O'Toole PW & Quigley EM (2012) Techniques used to characterize the gut microbiota: a guide for the clinician. Nat Rev Gastroenterol Hepatol 9, 312-322.
3. Eckburg PB, Bik EM, Bernstein CN et al. (2005) Diversity of the human intestinal microbial flora. Science 308, 1635-1638.
4. Carroll IM, Ringel-Kulka T, Keku TO et al. (2011) Molecular analysis of the luminal-and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 301, G799-G807.
5. Araujo-Perez F, McCoy AN, Okechukwu C et al. (2012) Differences in microbial signatures between rectal mucosal biopsies and rectal swabs. Gut Microbes 3, 530-535.
6. Rajilic-Stojanovic M, Heilig HG, Molenaar D et al. (2009) Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol 11, 1736-1751.
7. The Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214.
8. Qin J, Li R, Raes J et al. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65.
9. Claesson MJ, Cusack S, O'Sullivan O et al. (2011) Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 108, Suppl. 1, 4586-4591.
10. Mihajlovski A, Dore J, Levenez F et al. (2010) Molecular evaluation of the human gut methanogenic archaeal micro-biota reveals an age-associated increase of the diversity. Environ Microbiol Rep 2, 272-280.
11. Faith JJ, Guruge JL, Charbonneau M et al. (2013) The long-term stability of the human gut microbiota. Science 341, 1237439.
12. Arumugam M, Raes J, Pelletier E et al. (2011) Enterotypes of the human gut microbiome. Nature 473, 174-180.
13. Huse SM, Ye Y, Zhou Y et al. (2012) A core human micro-biome as viewed through 16S rRNA sequence clusters. PLoS ONE 7, e34242.
14. Jeffery IB, Claesson MJ, O'Toole PW et al. (2012) Categorization of the gut microbiota: enterotypes or gradients? Nat Rev Microbiol 10, 591-592.
15. Zoetendal EG, Akkermans AD & De Vos WM (1998) Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 64, 3854-3859.
16. Dethlefsen L, Huse S, Sogin ML et al. (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6, e280.
17. Jernberg C, Lofmark S, Edlund C et al. (2007) Long-term ecological impacts of antibiotic administration on the human intestinal microbiotia. ISME J 1, 56-66.
18. Cho I, Yamanishi S, Cox L et al. (2012) Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488, 621-626.
19. O'Toole PW & Claesson MJ (2010) Gut microbiota: changes throughout the lifespan from infancy to elderly. Int Dairy J 20, 281-291.
20. Adlerberth I & Wold AE (2009) Establishment of the gut microbiota in Western infants. Acta Paediatr 98, 229-238.
21. Favier CF, Vaughan EE, De Vos WM et al. (2002) Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 68, 219-226.
22. Palmer C, Bik EM, DiGiulio DB et al. (2007) Development of the human infant intestinal microbiota. PLoS Biol 5, 1556-1572.
23. Yatsunenko T, Rey FE, Manary MJ et al. (2012) Human gut microbiome viewed across age and geography. Nature 486, 222-227.
24. Turroni F, Peano C, Pass DA et al. (2012) Diversity of bifidobacteria within the infant gut microbiota. PLoS ONE 7, e36957.
25. Dominguez-Bello MG, Costello EK, Contreras M et al. (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107, 11971-11975.
26. Walker WA (2013) Initial intestinal colonization in the human infant and immune homeostasis. Ann Nutr Metab 63, Suppl. 2, 8-15.
27. Niino Y (2011) The increasing cesarean rate globally and what we can do about it. Biosci Trends 5, 139-150.
28. Sela DA & Mills DA (2010) Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosac-charides. Trends Microbiol 18, 298-307.
29. Woodmansey EJ (2007) Intestinal bacteria and ageing. J Appl Microbiol 102, 1178-1186.
30. Mueller S, Saunier K, Hanisch C et al. (2006) Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72, 1027-1033.
31. Hopkins MJ & Macfarlane GT (2002) Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 51, 448-454.
32. Woodmansey EJ, McMurdo ME, Macfarlane GT et al. (2004) Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 70, 6113-6122.
33. Franceschi C, Bonafe M, Valensin S et al. (2000) Inflamm-aging. An evolutionary perspective on immunose-nescence. Ann N Y Acad Sci 908, 244-254.
34. van Tongeren SP, Slaets JP, Harmsen HJ et al. (2005) Fecal microbiota composition and frailty. Appl Environ Microbiol 71, 6438-6442.
35. Biagi E, Nylund L, Candela M et al. (2010) Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE 5, e10667.
36. de Vos WM & de Vos EA (2012) Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr Rev 70, Suppl. 1, S45-S56.
37. Sekirov I, Russell SL, Antunes LC et al. (2010) Gut micro-biota in health and disease. Physiol Rev 90, 859-904.
38. Manichanh C, Borruel N, Casellas F et al. (2012) The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 9, 599-608.
39. Jostins L, Ripke S, Weersma RK et al. (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124.
40. Frank DN, St Amand AL, Feldman RA et al. (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 104, 13780-13785.
41. Manichanh C, Rigottier-Gois L, Bonnaud E et al. (2006) Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205-211.
42. Sokol H, Pigneur B, Watterlot L et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105, 16731-16736.
43. Karlsson FH, Tremaroli V, Nookaew I et al. (2013) Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99-103.
44. Qin J, Li Y, Cai Z et al. (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60.
45. Vrieze A, Van Nood E, Holleman F et al. (2012) Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913-916. e7.
46. Smith MI, Yatsunenko T, Manary MJ et al. (2013) Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 339, 548-554.
47. Jemal A, Bray F, Center MM et al. (2011) Global cancer statistics. CA Cancer J Clin 61, 69-90.
48. Wu S, Rhee KJ, Albesiano E et al. (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17T cell responses. Nat Med 15, 1016-1022.
49. Arthur JC, Perez-Chanona E, Muhlbauer M et al. (2012) Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120-123.
50. Castellarin M, Warren RL, Freeman JD et al. (2012) Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 22, 299-306.
51. Kostic AD, Chun E, Robertson L et al. (2013) Fusobacterium nucleatum potentiates intestinal tumorigen-esis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207-215.
52. Kostic AD, Gevers D, Pedamallu CS et al. (2012) Genomic analysis identifies association of Fusobacterium with color-ectal carcinoma. Genome Res 22, 292-298.
53. O'Connor EM (2013) The role of gut microbiota in nutritional status. Curr Opin Clin Nutr Metab Care 16, 509-516.
54. LeBlanc JG, Milani C, de Giori GS et al. (2013) Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol 24, 160-168.
55. Collins MD, Fernandez F & Howarth OW (1985) Isolation and characterization of a novel vitamin-K from Eubacterium lentum. Biochem Biophys Res Commun 133, 322-328.
56. Mathers JC, Fernandez F, Hill MJ et al. (1990) Dietary modification of potential vitamin K supply from enteric bacterial menaquinones in rats. Br J Nutr 63, 639-652.
57. Kashyap PC, Marcobal A, Ursell LK et al. (2013) Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut micro-biota. Proc Natl Acad Sci USA 110, 17059-17064.
58. Claesson MJ, Jeffery IB, Conde S et al. (2012) Gut micro-biota composition correlates with diet and health in the elderly. Nature 488, 178-185.
59. De Filippo C, Cavalieri D, Di Paola M et al. (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 107, 14691-14696.
60. Wu GD, Chen J, Hoffmann C et al. (2011) Linking longterm dietary patterns with gut microbial enterotypes. Science 334, 105-108.
61. Tremaroli V & Backhed F (2012) Functional interactions between the gut microbiota and host metabolism. Nature 489, 242-249.
62. Tolhurst G, Heffron H, Lam YS et al. (2012) Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61, 364-371.
63. Lin HV, Frassetto A, Kowalik EJ Jr et al. (2012) Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS ONE 7, e35240.
64. Ford H & Frost G (2010) Glycaemic index, appetite and body weight. Proc Nutr Soc 69, 199-203.
65. Kimura I, Ozawa K, Inoue D et al. (2013) The gut micro-biota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun 4, 1829.
66. Ley RE, Turnbaugh PJ, Klein S et al. (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023.
67. Duncan SH, Lobley GE, Holtrop G et al. (2008) Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes 32, 1720-1724.
68. Schwiertz A, Taras D, Schafer K et al. (2009) Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18, 190-195.
69. Simoes CD, Maukonen J, Kaprio J et al. (2013) Habitual dietary intake is associated with stool microbiota composition in monozygotic twins. J Nutr 143, 417-423.
70. Finucane MM, Sharpton TJ, Laurent TJ et al. (2014) A taxonomic signature of obesity in the microbiome? Getting to the guts of the matter. PLoS ONE 9, e84689.
71. David LA, Maurice CF, Carmody RN et al. (2013) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559-563.
72. Turnbaugh PJ, Hamady M, Yatsunenko T et al. (2009) A core gut microbiome in obese and lean twins. Nature 457, 480-484.
73. Jumpertz R, Le DS, Turnbaugh PJ et al. (2011) Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr 94, 58-65.
74. Russo P, Lauria F & Siani A (2010) Heritability of body weight: moving beyond genetics. Nutr Metab Cardiovasc Dis 20, 691-697.
75. Le Chatelier E, Nielsen T, Qin J et al. (2013) Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541-546.
76. Cotillard A, Kennedy SP, Kong LC et al. (2013) Dietary intervention impact on gut microbial gene richness. Nature 500, 585-588.
77. Backhed F, Manchester JK, Semenkovich CF et al. (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 104, 979-984.
78. Turnbaugh PJ, Ridaura VK, Faith JJ et al. (2009) The effect of diet on the human gut microbiome: a metage-nomic analysis in humanized gnotobiotic mice. Sci Transl Med 1, 6-14.
79. Fleissner CK, Huebel N, Abd El-Bary MM et al. (2010) Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr 104, 919-929.
80. Ridaura VK, Faith JJ, Rey FE et al. (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341, 1241214.
81. Turnbaugh PJ, Ley RE, Mahowald MA et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031.
82. Turnbaugh PJ, Backhed F, Fulton L et al. (2008) Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213-223.
83. Cani PD, Amar J, Iglesias MA et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772.
84. Pendyala S, Walker JM & Holt PR (2012) A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 142, 1100-1101. e2.
85. Delzenne NM, Neyrinck AM & Cani PD (2011) Modulation of the gut microbiota by nutrients with prebio-tic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact 10, Suppl. 1, S10.
86. Matias I & Di Marzo V (2007) Endocannabinoids and the control of energy balance. Trends Endocrinol Metab 18, 27-37.
87. Muccioli GG, Naslain D, Backhed F et al. (2010) The endocannabinoid system links gut microbiota to adipogen-esis. Mol Syst Biol 6, 392.
88. Pagotto U, Marsicano G, Cota D et al. (2006) The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 27, 73-100.
89. Bluher M, Engeli S, Kloting N et al. (2006) Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55, 3053-3060.
90. Geurts L, Lazarevic V, Derrien M et al. (2011) Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front Microbiol 2, 149.
91. Vitali B, Ndagijimana M, Maccaferri S et al. (2012) An in vitro evaluation of the effect of probiotics and prebiotics on the metabolic profile of human microbiota. Anaerobe 18, 386-391.
92. Gibson GR & Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125, 1401-1412.
93. Walton G, Swann J & Gibson G. (2013) Prebiotics. In The Prokaryotes, pp. 25-43. [Rosenberg E, DeLong E, Lory S, Stackebrandt E, Thompson F, editors]. Berlin, Heidelberg: Springer-Verlag.
94. Lomax AR & Calder PC (2009) Prebiotics, immune function, infection and inflammation: a review of the evidence. Br J Nutr 101, 633-658.
95. Manning TS & Gibson GR (2004) Microbial-gut interactions in health and disease. Prebiotics. Best Pract Res Clin Gastroenterol 18, 287-298.
96. Davis LM, Martinez I, Walter J et al. (2011) Barcoded pyr-osequencing reveals that consumption of galactooligosac-charides results in a highly specific bifidogenic response in humans. PloS ONE 6, e25200.
97. Macfarlane GT, Steed H & Macfarlane S (2008) Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol 104, 305-344.
98. Kleessen B, Sykura B, Zunft HJ et al. (1997) Effects of inu-lin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr 65, 1397-1402.
99. Bouhnik Y, Achour L, Paineau D et al. (2007) Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers. Nutr J 6, 42.
100. Guigoz Y, Rochat F, Perruisseau-Carrier G et al. (2002) Effects of oligosaccharide on the fecal flora and nonspecific immune system in elderly people. Nutr Res 22, 13-25.
101. Vulevic J, Drakoularakou A, Yaqoob P et al. (2008) Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr 88, 1438-1446.
102. Silk DB, Davis A, Vulevic J et al. (2009) Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 29, 508-518.
103. Vulevic J, Juric A, Tzortzis G et al. (2013) A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr 143, 324-331.
104. O'Keefe SJ, Ou J, Delany JP et al. (2011) Effect of fiber supplementation on the microbiota in critically ill patients. World J Gastrointest Pathophysiol 2, 138-145.
105. Hooda S, Boler BM, Serao MC et al. (2012) 454 pyrose-quencing reveals a shift in fecal microbiota of healthy adult men consuming polydextrose or soluble corn fiber. J Nutr 142, 1259-1265.
106. Neyrinck AM, Possemiers S, Druart C et al. (2011) Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS ONE 6, e20944.
107. Walker AW, Ince J, Duncan SH et al. (2011) Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 5, 220-230.
108. Haenen D, Zhang J, Souza da Silva C et al. (2013) A diet high in resistant starch modulates microbiota composition, SCFA concentrations, and gene expression in pig intestine. J Nutr 143, 274-283.
109. Geier MS, Butler RN & Howarth GS (2006) Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer? Cancer Biol Ther 5, 1265-1269.
110. Ramirez-Farias C, Slezak K, Fuller Z et al. (2009) Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium praus-nitzii. Br J Nutr 101, 541-550.
111. Kleessen B, Schwarz S, Boehm A et al. (2007) Jerusalem artichoke and chicory inulin in bakery products affect faecal microbiota of healthy volunteers. Br J Nutr 98, 540-549.
112. Biagi E, Candela M, Fairweather-Tait S et al. (2012) Aging of the human metaorganism: the microbial counterpart. Age (Dordr) 34, 247-267.
113. Bartosch S, Fite A, Macfarlane GT et al. (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 70, 3575-3581.
114. Ng KM, Ferreyra JA, Higginbottom SK et al. (2013) Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502, 96-99.
115. Simren M, Barbara G, Flint HJ et al. (2013) Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 62, 159-176.
116. Roberfroid M, Gibson GR, Hoyles L et al. (2010) Prebiotic effects: metabolic and health benefits. Br J Nutr 104, Suppl. 2, S1-63.
117. Walton GE, van den Heuvel EG, Kosters MH et al. (2012) A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age. Br J Nutr 107, 1466-1475.
118. Sanchez JI, Marzorati M, Grootaert C et al. (2009) Arabinoxylan-oligosaccharides (AXOS) affect the protein/carbohydrate fermentation balance and microbial population dynamics of the Simulator of Human Intestinal Microbial Ecosystem. Microb Biotechnol 2, 101-113.
119. Martinez I, Kim J, Duffy PR et al. (2010) Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS ONE 5, e15046.
120. Salminen S & van Loveren H (2012) Probiotics and pre-biotics: health claim substantiation. Microb Ecol Health Dis 23 (http://dx.doi.org/10.3402/mehd.v23i0.18568).
121. Toward R, Montandon S, Walton G et al. (2012) Effect of prebiotics on the human gut microbiota of elderly persons. Gut Microbes 3, 57-60.
122. Laparra JM & Sanz Y (2010) Interactions of gut micro-biota with functional food components and nutraceuti-cals. Pharmacol Res 61, 219-225.